Jakafi 10 MG tablet 60S
Ended Awarded Last action
- Contract number
- SPE2DR26FKAQ3
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $24,730
Award facts
- Contract value 100% obligated
- $24,729.64 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $24,729.64 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Jakafi 10 mg tablets (60-count). The award, issued on December 15, 2025, with an ultimate completion date of December 16, 2025, was made under firm fixed-price terms with no set-aside designation, reflecting the contractor's competitive capability in unrestricted federal procurement. DMS Pharmaceutical Group will deliver the product to Park Ridge, Illinois, to support the pharmaceutical supply needs of the Department of Defense healthcare system.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (IDC) with the DLA's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, designated as contract SPE2DR. The parent IDC, valued at $499,999,999 with completion through December 31, 2036, positions DMS Pharmaceutical Group as one of multiple regional prime vendor contractors within the broader $30.3 billion PPV-G GEN V acquisition strategy designed to provide comprehensive pharmaceutical products and medical consumables to support Department of Defense military healthcare facilities worldwide. As the sole contractor on this delivery order with no identified subcontractors, DMS Pharmaceutical Group leverages its established federal contracting experience and product portfolio spanning branded and generic prescription medications, biologics, and specialty pharmaceuticals to fulfill the recurring medical supply requirements of the federal military medical system.
Quick answers
Who was awarded contract SPE2DR26FKAQ3?
SPE2DR26FKAQ3 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 15, 2025.
How much is contract SPE2DR26FKAQ3 worth?
The government has obligated $24,730 on SPE2DR26FKAQ3.
Is contract SPE2DR26FKAQ3 an order under another contract?
Yes. SPE2DR26FKAQ3 is a delivery order under SPE2DR25D9365, an indefinite delivery contract.
Was contract SPE2DR26FKAQ3 competed?
The extent of competition for SPE2DR26FKAQ3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award